SCHEMBL9100015

SCHEMBL9100015

CNC(=O)Oc1cc(Oc2cccc(-c3c[nH]c(C(=O)Nc4cc(C(F)(F)F)ccc4N(C)C)c3)c2)ccn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.38
RET P07949 3/20 0.38
AURKA O14965 2/20 0.38
ABL1 P00519 2/20 0.38
LCK P06239 2/20 0.38
LYN P07948 2/20 0.38
SRC P12931 2/20 0.38
SYK P43405 2/20 0.38
MAPK14 Q16539 2/20 0.38
PLK4 O00444 1/20 0.38
MAPK13 O15264 1/20 0.38
JAK2 O60674 1/20 0.38
MAP4K4 O95819 1/20 0.38
FYN P06241 1/20 0.38
ROS1 P08922 1/20 0.38
RPS6KB1 P23443 1/20 0.38
EPHA2 P29317 1/20 0.38
TYK2 P29597 1/20 0.38
AXL P30530 1/20 0.38
FRK P42685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9104786 0.89 RAF1 (0.49) KDRRETAURKAABL1LCK
SCHEMBL4470285 0.89 KDR (0.50) KDRRETAURKAABL1LCK
SCHEMBL9098846 0.87 KDR (0.49) KDRRETAURKAABL1LCK
SCHEMBL5724635 0.84 KDR (0.53) KDRRETAURKAABL1LCK
SCHEMBL9100306 0.82 KDR (0.41) KDRTEKEGFR
SCHEMBL9099762 0.81 KDR (0.42) KDRRETAURKAABL1LCK
SCHEMBL9100020 0.81 RAF1 (0.55) KDRRETAURKAABL1LCK
SCHEMBL9103475 0.81 RAF1 (0.37) KDRRAF1BRAFMAPT
SCHEMBL9101755 0.80 RET (0.55) KDRRETAURKAABL1LCK
SCHEMBL9105151 0.80 RAF1 (0.50) KDRRETAURKAABL1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685125-B1 Pyrrole derivatives useful for the treatment of proliferative diseases MERCK PATENT GMBH (DE) 2012-06-06 EP claimed
EP-1685125-B1 Pyrrole derivatives useful for the treatment of proliferative diseases MERCK PATENT GMBH (DE) 2012-06-06 EP disclosed